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S U M M A R Y
In principle, one has to differentiate between a mere colonization and an invasive fungal infection (IFI)
with quite different clinical manifestations and consequences. If the term invasive were used in its
proper sense (expressis verbis), all fungal infections could be called invasive, even a fungal keratitis or an
infection of the hairs by dermatophytes. In general, however, the term IFI is used only to characterize
systemic, generalized, deep-seated, visceral and severe, life-threatening fungal infections, in contrast to
superﬁcial, local, benign, self-limiting fungal diseases. The term IFI as used generally is thus misleading,
confusing, and not at all helpful to correctly differentiate mild, moderate, and severe fungal infections.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journa l homepage: www.e lsev ier .com/ locate / i j idIFI = invasive fungal infections
Clinicians often use the term invasive fungal infection (IFI) to
describe a severe, systemic infection with yeasts or moulds.1
Recently, a revised deﬁnition has been given by an expert group.2
But does this term really help to distinguish invasive fungal
infections from other fungal infections?
Dermatophytes are able to penetrate the keratinized layers of
the skin. This ﬁrst step triggers an inﬂammatory response
characterized by an attraction of neutrophilic granulocytes and
macrophages. Furthermore, this local infection called tinea, leads
to a systemic T-lymphocyte response as well as to a production of
antibodies, which can be detected in the blood. In some instances
such immune phenomenamay be responsible for pathologic tissue
reactions even at distant, non-infected sites.3 Some dermato-
phytes, for example Trichophyton violaceum, are characterized by
an invasion of hair shafts and an endothrix parasitism within the
hairs of the affected patient.4 Because serum components will
inhibit the growth of dermatophytes and because keratin, the
essential nutrient, is not available in deeper tissues, infections will
remain superﬁcial.3,5 But any way, these local infections will cause
a systemic immune response.
Following local damage, Fusarium spp are able to penetrate into
the cornea, to propagate into the direct vicinity, and to inducemore* Tel.: +49 6221 3432 342; fax: +49 6221 3432 8342.
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restricted to the portal of entry.
Candida albicans frequently colonizes the vagina of women
without inducing any symptoms. This saprophytic state can switch
to an invasive situation under certain predisposing conditions. In
pregnant women and women taking oral contraceptives these
fungi, which possess several virulence factors, invade the epithelial
layer and trigger a local inﬂammatory reaction leading to vaginal
mycoses.7,8 Other dermal and mucosal sites may ﬁrst be colonized
and then invaded by C. albicans, too, inducing thrush. In
immunocompromised patients these opportunistic fungi tend to
inﬁltrate deeper tissues and may even disseminate to distant
organs, inducing visceral candidiasis.3 Both local and disseminated
infections are due to invasion!
Cryptococcus neoformans is widespread in nature. When these
yeasts are inhaled by humans or animals they are able to survive
within the alveolarmacrophages of the host andmultiply locally in
the lung, inducing a focal inﬂammatory reaction. Although in most
instances these transitional cryptococcoma are not recognized and
are overlooked, they may function as the secondary source for a
dissemination to other organs such as the brain, prostate, etc.9
Quite similarly, spores of dimorphic fungi, such as Coccidioides
immitis, are distributed via air and are inhaled. Initially, they
invade the lung and induce a localized, nodular inﬂammatory
response; in most instances a self-limiting pulmonary infection
occurs; occasionally the lung infection persists and the fungi
inﬁltrate larger zones. In particular when cell-mediated immunity
is impaired, the fungi spread from the primary manifestation siteses. Published by Elsevier Ltd. All rights reserved.
H. Hof / International Journal of Infectious Diseases 14 (2010) e458–e459 e459to other, distant organs where they may also produce granulo-
matous reactions. The consequences of infection with C. immitis
may vary, and the local area of tissue damage in an organ may be
small, i.e. nodular, or large, i.e., diffuse.10 Obviously, all stages of
this fungal infection are invasive!
Zygomycetes commonly residing in the environment are
taken up by inhalation into the nasal sinuses. Whereas in most
instances this confrontation does not induce harm, occasionally
they invade the mucosal layer. These initial stages of an invasive
fungal infection are often overlooked, since the symptoms are not
yet overt. However, in susceptible individuals presenting
diabetes or hematologic malignancies, this ﬁrst step of a local
infection may be followed by dissemination into various internal
organs and even into bone structures;11 then the prognosis is
rather poor.
Spores of Aspergillus fumigatus are almost ubiquitous in nature;
they frequently reach the respiratory tract. If they are deeply
inhaled, they may be phagocytosed by the alveolar macrophages.
Whereas in general the spores are eliminated rapidly, in an
immunocompromised host, for example one treated with corti-
costeroids, the fungal cells survive and hyphae may penetrate into
the lung tissue. In many such cases the aspergillosis of the lung is
further complicated by hematogenous dissemination to virtually
all distant organs.12 Some forms of invasive aspergillosis of the
lung are, however, preceded by a superﬁcial, localized stage. For
example the aspergilli may settle in the nasal sinuses and sphenoid
sinuses13,14 and occasionally they may persist and even grow
locally, producing a so-called fungus ball, i.e., a non-invasive,
extramucosal mycetoma. This massive assembly of fungal hyphae
is not a common source of invasion of the surrounding tissues;
occasionally, however, this internal colonization shifts into an
infection due to invasion of the mucosal layers and the adjacent
bone structures.15 Such fungus balls may also develop in
preformed cavities of the lung. The non-invasive fungus ball
may reside within the host for decades in these deep-seated
locations, before the fungal hyphae eventually penetrate into the
lung tissue and induce pulmonary aspergillosis.16 An uncommon
manifestation of invasive pulmonary aspergillosis is tracheobron-
chitis;17 in such cases the infection is restricted to the mucosa
leading to the local obstruction of the airways. Large and extended
scald or burn wounds of the skin are often contaminated aerially
with spores of A. fumigatus. Fungal colonies spread over these
surfaces; this quite superﬁcial infection is often accompanied by an
invasion of hyphae into the upper layer of the wounds, leading to a
limited inﬂammatory reaction. Obviously, A. fumigatus can either
colonize or invade a host more or less intensively.
In conclusion, one has to differentiate between a mere
saprophytic colonization and an invasive fungal infection with
quite different clinical manifestations and consequences. If the
term invasive were used in its proper sense (expressis verbis), all
fungal infections could be called invasive, not only those with
radiological signs or elevated galactomannan levels in the serum!2
In general, however, the term IFI is used exclusively to characterize
a systemic, generalized, deep-seated, visceral and severe, life-
threatening fungal infection,1,2 rather than a superﬁcial, local,
benign, self-limiting fungal disease. Apart from the ‘so-called IFIs’,
such as a lung aspergillosis, it should be kept in mind that the so-
called non-IFI fungal infections, such as skin infections by
dermatophytes, are also invasive.Thus this term, as used generally, is misleading, confusing, and
not at all helpful, since invasiveness can tell the difference between
colonization and infection, but obviously is inadequate to
differentiate clearly between mild, moderate and severe fungal
disease. For these various entities with quite different prognoses
and which each require quite different therapeutic approaches,
another, more convenient terminology is warranted; for example
the term ominous or life-threatening fungal infection would point
out the urgent need for diagnostic and therapeutic measurements.
The term invasive fungal disease (IFD), proposed recently,2 is
not a good alternative to describe only the advanced stages of
fungal infections, because an initial, local stage of disseminated
fungal infection, a superﬁcial mucosal infection, a fungal keratitis,
or even an infection of the hairs by dermatophytes, which are all a
consequence of invasion by fungi, represent deﬁnite signs of
sickness and also merit this label.
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